Biofilm Maturation Inhibition
Biofilm Maturation Inhibition - Related Videos
03:47
Microscopic Assessment of Enzyme-Mediated Inhibition of Biofilm Formation
0 Views •
2026
Source: Tay, S. B., et.al. Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases. J. Vis. Exp. (2016)This video demonstrates the process of inhibiting biofilm formation by introducing an enzyme that disrupts bacterial cell signaling. The enzyme prevents the bacteria from producing extracellular polymeric substances, thereby reducing biofilm development on a glass-bottomed microdish. Finally, the biofilm structure is visualized using fluorescent lectins and...
09:03
Growth of Mycobacterium tuberculosis Biofilms
0 Views •
Cited by 79 •
2012
Mycobacterium tuberculosis forms drug tolerant biofilms when cultured in certain conditions. Here we describe methods for culturing M. tuberculosis biofilms and determining the frequency of drug tolerant persisters. These protocols will be useful for further studies into the mechanisms of drug tolerance in M. tuberculosis.
03:57
Microtiter Dish Biofilm Formation Assay
0 Views •
Cited by 2243 •
2011
The assay describes a rapid means to measure early biofilm formation in bacteria and fungi. This method uses a microtiter plate as the substratum for microbial biofilm formation, and the biofilm is visualized using crystal violet strain. The assay provides either a qualitative or quantitative assay for early biofilm formation.
03:54
An In Vitro Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilm
0 Views •
2025
This video demonstrates an in vitro technique to study the effect of antibodies on fungal biofilms. The pathogenic fungus Candida tropicalis secretes a virulence factor secreted aspartyl proteinase 2 (Sap2), facilitating biofilm formation. Upon introducing a heat-inactivated serum containing Sap2-specific antibodies that inhibit biofilm maturation, the viability of the fungal cells is assessed using a chromogenic assay.
10:17
Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors
0 Views •
Cited by 28 •
2016
This study presents the development of reproducible methodologies to study biofilm inhibitors and their effects on Bacillus subtilis multicellularity.
FAQs
Cell adhesion provides the foothold from which an attached microbial population can develop further organization. Interfering with this step may keep cells from progressing toward a more stable community state, making maturation inhibition distinct from approaches that act only after a mature biofilm has formed. In infection research, this strategy focuses on preventing structural development at an early stage.
Quorum sensing is one of the microbial processes that can be disrupted to delay biofilm development. Because maturation depends on coordinated community behavior, interfering with this signaling route may prevent an early attached population from acquiring the organization associated with a mature biofilm. This provides a mechanism-focused alternative to relying solely on antimicrobial activity against individual microbial cells.
The extracellular polymeric substance matrix stabilizes biofilm architecture and contributes to the community state that limits antimicrobial penetration. Inhibiting its production can therefore weaken structural development before the biofilm becomes fully established. This mechanism is relevant when the goal is to improve access of conventional antimicrobial treatments to microbial cells within or associated with the developing community.
Mature biofilms can resist host immune clearance and conventional treatment more effectively than early developing communities. Delaying maturation may reduce the protective organization that contributes to this persistence, although the approach is intended to complement rather than replace antimicrobial treatment. In immunology and infection research, this distinction helps explain why community-state interventions may improve treatment outcomes.
Evaluation should focus on whether an intervention delays the transition from an early attached state toward a structured, matrix-embedded community. Researchers can also examine whether the intervention improves antimicrobial activity, since that outcome connects maturation control with treatment relevance. These endpoints distinguish a strategy that changes biofilm development from one that acts only on already established microbial cells.
The approach is especially relevant to microbial persistence on tissues and medical devices, where a developing community may become difficult to clear after maturation. Preventing or delaying structural development could reduce persistence in these settings and support more effective treatment strategies. Its value lies in addressing the protective community state rather than focusing exclusively on free microbial cells.
Maturation inhibitors can be paired with antimicrobial treatments so that each addresses a different feature of infection: one limits development of the protective community state, while the other targets microbial cells. This combined strategy may improve antimicrobial activity and reduce persistence. It is particularly relevant when mature biofilm architecture and limited antimicrobial penetration undermine conventional treatment alone.